سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study

Publish Year: 1403
Type: Journal paper
Language: English
View: 48

This Paper With 8 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_IJRM-22-10_001

Index date: 11 December 2024

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study abstract

Background: Currently, frozen embryo transfers (FET) account for 41% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only vaginal progesterone during FET cycles results in a lower ongoing pregnancy rate. Objective: This study aimed to investigate whether replacing intramuscular (IM) progesterone with oral dydrogesterone in FET cycles affects pregnancy outcomes or not. Materials and Methods: In this cross-sectional study, pregnancy outcomes were analyzed in women who underwent cleavage stage FET during an endometrial preparation cycle using hormone replacement therapy at Yazd Reproductive Sciences Institute, Yazd, Iran, between April 2023 and November 2023. The study examined 2 groups based on a luteal phase support regimen: the dydrogesterone group, which received vaginal progesterone and oral dydrogesterone, and the IM progesterone group, which received vaginal progesterone and IM progesterone. Data were extracted from patient files to compare outcomes between the 2 groups. Results: A total of 960 cycles meeting the inclusion criteria were analyzed, with 292 women in the dydrogesterone group and 668 women in the IM progesterone group, and pregnancy outcomes were compared between the 2 groups. The chemical pregnancy rates (28.4% vs. 29.9%, p = 0.636), clinical pregnancy rates (25.3% vs. 26.9%, p = 0.604), and ongoing pregnancy rates (21.9% vs. 23.8%, p = 0.525) were lower and miscarriage rates (14.7% vs. 11.7%, p = 0.210) were higher in dydrogesterone group compared to IM progesterone group, although this difference was not statistically significant. Conclusion: Based on the ease of use and similar pregnancy outcomes of oral dydrogesterone, it can potentially replace the daily injections of IM progesterone.

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study Keywords:

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study authors

Sahereh Arabian

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Maryam Eftekhar

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Saeideh Dashti

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Nahid Homayoon

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Elham Nikfarjam

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara ...
Duijkers I, Klingmann I, Prinz R, Wargenau M, Hrafnsdottir S, ...
Dashti S, Eftekhar M. Luteal-phase support in assisted reproductive technology: ...
Rao KA, Rao VA, Devi R. Principles and practice of ...
Coombes Z, Plant K, Freire C, Basit AW, Butler P, ...
Piette PC. The pharmacodynamics and safety of progesterone. Best Pract ...
Di Renzo GC, Tosto V, Tsibizova V. Progesterone: History, facts, ...
Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, ...
Jalaliani S, Davar R, Akbarzadeh F, Emami F, Eftekhar M. ...
Mohammed A, Woad KJ, Mann GE, Craigon J, Raine-Fenning N, ...
Pabuçcu EG, Pabuçcu R, Evliyaoglu Ozdegirmenci O, Bostancı Durmus A, ...
Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst ...
Devine K, Richter KS, Jahandideh S, Widra EA, McKeeby JL. ...
Homayoon N, Arabian S, Mangoli E, Bayati F, Eftekhar M. ...
Child T, Leonard SA, Evans JS, Lass A. Systematic review ...
Simon V, Robin G, Keller L, Ternynck C, Jonard S, ...
Ikechebelu JI, Dim CC, Eleje GU, Joe-Ikechebelu N, Okpala BC, ...
Vidal A, Dhakal C, Werth N, Weiss JM, Lehnick D, ...
Salehpour S, Tamimi M, Saharkhiz N. Comparison of oral dydrogesterone ...
Simon JA, Robinson DE, Andrews MC, Hildebrand III JR, Rocci ...
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase ...
Yang D-Z, Griesinger G, Wang W, Gong F, Liang X, ...
Bachar G, Haskia C, Fainaru O. Comparable outcomes using oral ...
نمایش کامل مراجع